Skip to main content
. 2021 Sep 30;63(5):1182–1193. doi: 10.5187/jast.2021.e92

Table 2. Impacts of skim milk powder concentration level and pH on the viability of encapsulated probiotics during incubation in simulated gastric juice and simulated intestinal juice1).

Time (min) Skim milk powder concentration level (% [w/w])2) pH3)
3 5 10 5.4 6.2
SGJ
 0 8.94 8.91 9.00 8.96 8.91
 30 7.81 8.01 8.01 8.72 8.01
 60 6.57 7.63 6.84 7.96 7.63
 120 6.04 6.98 6.92 7.70 6.98
 Overall (0–120)4) 7.34 7.88 7.69 8.33 7.88
 Pooled SD 0.11 0.09
p-value
 Treat5) 0.0001 < 0.0001
 Time6) < 0.0001 < 0.0001
 Treat × Time7) < 0.0001 0.0003
SIJ
 0 8.94 8.91 9.00 8.96 8.91
 30 8.87 8.94 8.94 8.72 8.94
 60 9.07 8.92 9.01 7.96 8.92
 120 8.92 8.91 9.00 7.70 8.91
 Overall (0–120) 8.95 8.92 8.99 8.33 8.92
 Pooled SD 0.11 0.10
p-value
 Treat 0.2581 0.3575
 Time 0.6490 0.8375
 Treat × Time 0.8613 0.8949
1)

Data are mean values of triplicates and are expressed as Log10 CFU/mL.

2)

Probiotics (Lactobacillus rhamnosus GG) were encapsulated in milk protein-based delivery system prepared with various skim milk powder concentration levels (3, 5, and 10% [w/w]) at pH 6.2.

3)

Probiotics (L. rhamnosus GG) were encapsulated in milk protein-based delivery system prepared with skim milk powder concentration level of 5% (w/w) at various pH (5.4 and 6.2).

4)

Mean values of overall incubation period.

5)

Probiotic encapsulation in milk protein-based delivery systems.

6)

Incubation time in minutes.

7)

Interaction between treat and time.

SGJ, simulated gastric juice; SIJ, simulated intestinal juice.